Healthcare -
Biotechnology - NASDAQ - US
$ 41.1
1.61 %
$ 2.66 B
Market Cap
-17.56
P/E
KYMR - LONG-TERM DEBT
Long-term Debt KYMR - Kymera Therapeutics, Inc.
78.3 M
LAST VALUE
65.12%
2 YEAR CAGR
188.34%
5 YEAR CAGR
0.00%
10 YEAR CAGR